Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,694.12 -6.81 -0.25%
FTSE 100 6,356.02 -18.19 -0.29%
DAX 8,223.03 -6.48 -0.08%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Achillion Pharmaceuticals Inc

+ Add to Watchlist

ACHN:US

8.0100 USD 0.0800 1.01%

As of 20:10:00 ET on 06/18/2013.

Company Profile for Achillion Pharmaceuticals Inc (ACHN)

Achillion Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops solutions for infectious diseases such as HIV, hepatitis, and resistant bacterial infections.

Contact Information

Achillion Pharmaceuticals Inc

300 George Street
New Haven, CT 06511
United States
Phone: 1-203-724-6000

Key Executives for Achillion Pharmaceuticals Inc (ACHN)

Milind S DeshpandePresident/CEOGautam ShahExec VP/Chief Compliance Ofcr
David ApelianExec VP/Chief Medical OfcrMary Kay FentonSenior VP/CFO
Joseph TruittSenior VP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil